Neural stem cells and cell replacement therapy: making the right cells

被引:36
作者
Bithell, A [1 ]
Williams, BP [1 ]
机构
[1] Inst Psychiat, Dept Psychol Med, London SE5 8AF, England
关键词
cell replacement therapy; embryonic stem cell; neural stem cell; neurological disorder;
D O I
10.1042/CS20040276
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The past few years have seen major advances in the field of NSC (neural stem cell) research with increasing emphasis towards its application in cell-replacement therapy for neurological disorders. However, the clinical application of NSCs will remain largely unfeasible until a comprehensive understanding of the cellular and molecular mechanisms of NSC fate specification is achieved. With this understanding will come an increased possibility to exploit the potential Of stem cells in order to manufacture transplantable NSCs able to provide a safe and effective therapy for previously untreatable neurological disorders. Since the pathology of each of these disorders is determined by the loss or damage of a specific neural cell population, it may be necessary to generate a range of NSCs able to replace specific neurons or glia rather than generating a generic NSC population. Currently, a diverse range of strategies is being investigated with this goal in mind. In this review, we focus on the relationship between NSC specification and differentiation and discuss how this information may be used to direct NSCs towards a particular fate.
引用
收藏
页码:13 / 22
页数:10
相关论文
共 78 条
  • [31] Musashi1: An evolutionally conserved marker for CNS progenitor cells including neural stem cells
    Kaneko, Y
    Sakakibara, S
    Imai, T
    Suzuki, A
    Nakamura, Y
    Sawamoto, K
    Ogawa, Y
    Toyama, Y
    Miyata, T
    Okano, H
    [J]. DEVELOPMENTAL NEUROSCIENCE, 2000, 22 (1-2) : 139 - 153
  • [32] Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity
    Kawasaki, H
    Mizuseki, K
    Nishikawa, S
    Kaneko, S
    Kuwana, Y
    Nakanishi, S
    Nishikawa, S
    Sasai, Y
    [J]. NEURON, 2000, 28 (01) : 31 - 40
  • [33] Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease
    Kim, JH
    Auerbach, JM
    Rodríguez-Gómez, JA
    Velasco, I
    Gavin, D
    Lumelsky, N
    Lee, SH
    Nguyen, J
    Sánchez-Pernaute, R
    Bankiewicz, K
    McKay, R
    [J]. NATURE, 2002, 418 (6893) : 50 - 56
  • [34] Dopaminergic neuronal differentiation from rat embryonic neural precursors by Nurr1 overexpression
    Kim, JY
    Koh, HC
    Lee, JY
    Chang, MY
    Kim, YC
    Chung, HY
    Son, H
    Lee, YS
    Studer, L
    McKay, R
    Lee, SH
    [J]. JOURNAL OF NEUROCHEMISTRY, 2003, 85 (06) : 1443 - 1454
  • [35] NEUROPATHOLOGICAL EVIDENCE OF GRAFT-SURVIVAL AND STRIATAL REINNERVATION AFTER THE TRANSPLANTATION OF FETAL MESENCEPHALIC TISSUE IN A PATIENT WITH PARKINSONS-DISEASE
    KORDOWER, JH
    FREEMAN, TB
    SNOW, BJ
    VINGERHOETS, FJG
    MUFSON, EJ
    SANBERG, PR
    HAUSER, RA
    SMITH, DA
    NAUERT, GM
    PERL, DP
    OLANOW, CW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (17) : 1118 - 1124
  • [36] Differentiation of embryonic stem cells to a neural fate: A route to re-building the nervous system?
    Lang, KJD
    Rathjen, J
    Vassilieva, S
    Rathjen, PD
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 2004, 76 (02) : 184 - 192
  • [37] Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells
    Lee, SH
    Lumelsky, N
    Studer, L
    Auerbach, JM
    McKay, RD
    [J]. NATURE BIOTECHNOLOGY, 2000, 18 (06) : 675 - 679
  • [38] Stem cell therapy for human neurodegenerative disorders - how to make it work
    Lindvall, O
    Kokaia, Z
    Martinez-Serrano, A
    [J]. NATURE MEDICINE, 2004, 10 (07) : S42 - S50
  • [39] Patterning the vertebrate neuraxis
    Lumsden, A
    Krumlauf, R
    [J]. SCIENCE, 1996, 274 (5290) : 1109 - 1115
  • [40] Marín O, 2000, J NEUROSCI, V20, P6063